BioRestorative Cost Of Revenue vs Total Revenue Analysis

BRTX Stock

USD 1.47 0.02 1.34%

BioRestorative Therapies financial indicator trend analysis is way more than just evaluating BioRestorative Therapies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BioRestorative Therapies is a good investment. Please check the relationship between BioRestorative Therapies Cost Of Revenue and its Total Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRestorative Therapies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.

Cost Of Revenue vs Total Revenue

Cost Of Revenue vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BioRestorative Therapies Cost Of Revenue account and Total Revenue. At this time, the significance of the direction appears to have strong relationship.

The correlation between BioRestorative Therapies' Cost Of Revenue and Total Revenue is 0.6. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Total Revenue in the same time period over historical financial statements of BioRestorative Therapies, assuming nothing else is changed. The correlation between historical values of BioRestorative Therapies' Cost Of Revenue and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of BioRestorative Therapies are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Cost Of Revenue i.e., BioRestorative Therapies' Cost Of Revenue and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.6

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Cost Of Revenue

Cost of Revenue is found on BioRestorative Therapies income statement and represents the costs associated with goods and services BioRestorative Therapies provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Total Revenue

Total revenue comprises all receipts BioRestorative Therapies generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from BioRestorative Therapies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BioRestorative Therapies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRestorative Therapies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy BioRestorative Stock please use our How to Invest in BioRestorative Therapies guide.Selling General Administrative is likely to drop to about 7.4 M in 2024. Issuance Of Capital Stock is likely to drop to about 2.2 M in 2024

BioRestorative Therapies fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Accounts Payable	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Current Assets	Treasury Stock	Short Term Debt	Current Deferred Revenue	Non Currrent Assets Other
Total Assets		0.15	-0.65	0.96	-0.64	0.95	-0.73	0.05	-0.29	0.24	-0.7	0.26	-0.84	-0.8	0.7	-0.05	-0.39	0.97	0.72	-0.31	0.84	0.97	0.38	-0.6	-0.47	-0.63
Other Current Liab	0.15		0.22	0.04	0.09	0.25	0.16	-0.25	-0.37	0.61	0.05	0.46	0.23	-0.44	-0.25	0.46	0.05	0.19	0.41	-0.3	0.34	0.19	0.11	0.17	0.12	-0.45
Total Current Liabilities	-0.65	0.22		-0.8	0.77	-0.57	0.94	-0.28	-0.33	0.29	0.74	0.04	0.59	0.32	-0.38	0.34	0.13	-0.57	-0.46	-0.26	-0.38	-0.57	-0.22	0.91	0.53	0.25
Total Stockholder Equity	0.96	0.04	-0.8		-0.72	0.89	-0.88	0.16	-0.13	0.12	-0.81	0.19	-0.82	-0.68	0.63	-0.18	-0.4	0.91	0.7	-0.22	0.74	0.91	0.38	-0.74	-0.58	-0.51
Accounts Payable	-0.64	0.09	0.77	-0.72		-0.6	0.73	-0.23	-0.35	0.35	0.41	0.11	0.44	0.39	-0.35	0.5	-0.1	-0.58	-0.53	-0.27	-0.45	-0.58	-0.34	0.53	0.6	0.48
Other Current Assets	0.95	0.25	-0.57	0.89	-0.6		-0.64	-0.23	-0.33	0.28	-0.64	0.22	-0.77	-0.9	0.64	0.02	-0.3	0.99	0.82	-0.23	0.93	0.99	0.49	-0.56	-0.42	-0.71
Total Liab	-0.73	0.16	0.94	-0.88	0.73	-0.64		-0.33	-0.17	0.12	0.88	-0.02	0.64	0.36	-0.38	0.38	0.36	-0.64	-0.55	0.01	-0.43	-0.64	-0.3	0.85	0.67	0.19
Intangible Assets	0.05	-0.25	-0.28	0.16	-0.23	-0.23	-0.33		0.24	-0.24	-0.24	0.1	0.02	0.34	-0.14	-0.35	-0.23	-0.19	-0.16	-0.22	-0.3	-0.2	-0.1	-0.2	-0.21	0.24
Common Stock	-0.29	-0.37	-0.33	-0.13	-0.35	-0.33	-0.17	0.24		-0.64	0.12	-0.52	0.18	0.52	-0.17	-0.59	0.6	-0.33	-0.32	0.76	-0.49	-0.33	-0.22	-0.18	-0.23	0.28
Property Plant Equipment	0.24	0.61	0.29	0.12	0.35	0.28	0.12	-0.24	-0.64		-0.19	0.78	-0.11	-0.42	0.05	0.62	-0.32	0.27	0.32	-0.62	0.38	0.27	0.28	0.11	0.14	-0.29
Short Long Term Debt Total	-0.7	0.05	0.74	-0.81	0.41	-0.64	0.88	-0.24	0.12	-0.19		-0.2	0.61	0.46	-0.28	0.15	0.58	-0.63	-0.64	0.29	-0.52	-0.63	-0.45	0.83	0.5	0.13
Property Plant And Equipment Net	0.26	0.46	0.04	0.19	0.11	0.22	-0.02	0.1	-0.52	0.78	-0.2		-0.12	-0.4	0.06	0.51	-0.14	0.21	0.25	-0.38	0.37	0.21	0.18	-0.1	0.36	-0.48
Net Debt	-0.84	0.23	0.59	-0.82	0.44	-0.77	0.64	0.02	0.18	-0.11	0.61	-0.12		0.53	-0.93	0.14	0.33	-0.84	-0.32	0.15	-0.6	-0.83	-0.11	0.56	0.34	0.39
Retained Earnings	-0.8	-0.44	0.32	-0.68	0.39	-0.9	0.36	0.34	0.52	-0.42	0.46	-0.4	0.53		-0.43	-0.24	0.2	-0.86	-0.84	0.25	-0.99	-0.86	-0.56	0.41	0.07	0.83
Cash	0.7	-0.25	-0.38	0.63	-0.35	0.64	-0.38	-0.14	-0.17	0.05	-0.28	0.06	-0.93	-0.43		-0.1	-0.14	0.73	0.11	-0.04	0.48	0.73	-0.08	-0.3	-0.18	-0.41
Non Current Assets Total	-0.05	0.46	0.34	-0.18	0.5	0.02	0.38	-0.35	-0.59	0.62	0.15	0.51	0.14	-0.24	-0.1		-0.24	0.02	0.11	-0.36	0.19	0.02	0.07	0.12	0.33	-0.12
Long Term Debt	-0.39	0.05	0.13	-0.4	-0.1	-0.3	0.36	-0.23	0.6	-0.32	0.58	-0.14	0.33	0.2	-0.14	-0.24		-0.32	-0.32	0.81	-0.23	-0.32	-0.23	0.21	0.4	-0.26
Cash And Short Term Investments	0.97	0.19	-0.57	0.91	-0.58	0.99	-0.64	-0.19	-0.33	0.27	-0.63	0.21	-0.84	-0.86	0.73	0.02	-0.32		0.74	-0.24	0.89	1.0	0.4	-0.55	-0.43	-0.67
Common Stock Shares Outstanding	0.72	0.41	-0.46	0.7	-0.53	0.82	-0.55	-0.16	-0.32	0.32	-0.64	0.25	-0.32	-0.84	0.11	0.11	-0.32	0.74		-0.29	0.86	0.74	0.78	-0.52	-0.43	-0.59
Non Current Liabilities Total	-0.31	-0.3	-0.26	-0.22	-0.27	-0.23	0.01	-0.22	0.76	-0.62	0.29	-0.38	0.15	0.25	-0.04	-0.36	0.81	-0.24	-0.29		-0.25	-0.24	-0.23	-0.17	0.19	-0.05
Other Stockholder Equity	0.84	0.34	-0.38	0.74	-0.45	0.93	-0.43	-0.3	-0.49	0.38	-0.52	0.37	-0.6	-0.99	0.48	0.19	-0.23	0.89	0.86	-0.25		0.89	0.59	-0.47	-0.14	-0.81
Total Current Assets	0.97	0.19	-0.57	0.91	-0.58	0.99	-0.64	-0.2	-0.33	0.27	-0.63	0.21	-0.83	-0.86	0.73	0.02	-0.32	1.0	0.74	-0.24	0.89		0.4	-0.55	-0.42	-0.67
Treasury Stock	0.38	0.11	-0.22	0.38	-0.34	0.49	-0.3	-0.1	-0.22	0.28	-0.45	0.18	-0.11	-0.56	-0.08	0.07	-0.23	0.4	0.78	-0.23	0.59	0.4		-0.35	-0.31	-0.36
Short Term Debt	-0.6	0.17	0.91	-0.74	0.53	-0.56	0.85	-0.2	-0.18	0.11	0.83	-0.1	0.56	0.41	-0.3	0.12	0.21	-0.55	-0.52	-0.17	-0.47	-0.55	-0.35		0.32	0.24
Current Deferred Revenue	-0.47	0.12	0.53	-0.58	0.6	-0.42	0.67	-0.21	-0.23	0.14	0.5	0.36	0.34	0.07	-0.18	0.33	0.4	-0.43	-0.43	0.19	-0.14	-0.42	-0.31	0.32		-0.14
Non Currrent Assets Other	-0.63	-0.45	0.25	-0.51	0.48	-0.71	0.19	0.24	0.28	-0.29	0.13	-0.48	0.39	0.83	-0.41	-0.12	-0.26	-0.67	-0.59	-0.05	-0.81	-0.67	-0.36	0.24	-0.14

Click cells to compare fundamentals

BioRestorative Therapies Account Relationship Matchups

BioRestorative Therapies fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.5M	4.3M	22.5M	16.4M	12.6M	13.2M
Other Current Liab	4.5M	609.2K	15.9K	5.5M	2.3M	1.7M
Total Current Liabilities	13.7M	1.0M	363.8K	440.3K	2.6M	2.5M
Total Stockholder Equity	(12.8M)	(1.3M)	21.6M	15.8M	10.0M	10.5M
Accounts Payable	2.0M	118.9K	50.8K	170.9K	189.4K	179.9K
Other Current Assets	35.2K	105.4K	436.2K	363.1K	305.2K	320.5K
Total Liab	14.2M	5.7M	856.5K	602.6K	2.6M	2.5M
Intangible Assets	739.2K	664.3K	589.7K	803.4K	713.7K	971.2K
Common Stock	7.8K	286.2K	353.0	369.0	471.0	447.45
Property Plant Equipment	658.3K	21.9K	395.8K	502.8K	578.2K	351.7K
Short Long Term Debt Total	7.8M	4.8M	670.7K	301.6K	162.3K	154.2K
Property Plant And Equipment Net	658.3K	495.8K	395.8K	502.8K	507.5K	420.0K
Net Debt	7.8M	1.7M	(20.4M)	(1.4M)	(722.1K)	(686.0K)
Retained Earnings	(78.6M)	(89.8M)	(134.1M)	(152.6M)	(146.7M)	(139.4M)
Cash	1.7K	3.1M	21.0M	1.7M	884.4K	840.2K
Non Current Assets Total	1.4M	1.2M	985.5K	1.3M	1.2M	1.3M
Long Term Debt	194.3K	523.9K	4.3M	191.0K	219.7K	208.7K
Cash And Short Term Investments	1.7K	3.1M	21.0M	14.7M	11.1M	11.6M
Common Stock Shares Outstanding	19.5K	394.7K	1.2M	3.6M	4.2M	4.4M
Liabilities And Stockholders Equity	1.5M	4.3M	22.5M	16.4M	12.6M	13.2M
Non Current Liabilities Total	521.9K	4.6M	492.7K	162.3K	186.7K	177.3K
Other Stockholder Equity	65.8M	88.2M	155.7M	146.6M	156.7M	164.5M
Total Current Assets	68.9K	3.2M	21.5M	15.1M	11.4M	12.0M
Short Term Debt	7.2M	316.7K	297.1K	278.7K	162.3K	154.2K
Net Tangible Assets	(13.5M)	(2.0M)	21.0M	15.0M	17.3M	18.1M
Short Long Term Debt	3.5M	3.6M	7.1M	59.0K	53.1K	50.4K
Net Receivables	32K	17K	5K	16K	19.3K	22.7K
Net Invested Capital	(5.6M)	2.9M	21.8M	15.8M	10.0M	5.9M
Net Working Capital	(13.7M)	2.1M	21.1M	14.7M	8.8M	9.2M
Capital Stock	7.8K	286.2K	15.8K	15.6K	17.9K	17.0K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for BioRestorative Stock Analysis

When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

BioRestorative Cost Of Revenue vs Total Revenue Analysis

Cost Of Revenue vs Total Revenue

Cost Of Revenue vs Total Revenue Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Total Revenue

BioRestorative Therapies fundamental ratios Correlations

BioRestorative Therapies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

BioRestorative Therapies fundamental ratios Accounts

Also Currently Popular

Additional Tools for BioRestorative Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Cash And Short Term Investments	+ 0.99	Other Current Assets
Total Current Assets	+ 0.99	Other Current Assets
Cash And Short Term Investments	+ 0.97	Total Assets
Total Current Assets	+ 0.97	Total Assets
Total Stockholder Equity	+ 0.96	Total Assets

Other Stockholder Equity	- 0.99	Retained Earnings
Cash	- 0.93	Net Debt
Retained Earnings	- 0.9	Other Current Assets
Total Liab	- 0.88	Total Stockholder Equity
Total Current Assets	- 0.86	Retained Earnings
Cash And Short Term Investments	- 0.86	Retained Earnings